Jefferson Capital JCAP Q1 2026 Earnings Beat Revenue NA EPS 073 Trump Urges China and Taiwan to Both Cool It Following Beijing Visit Michael Burry Warns Investors to Reject Greed as AI Stocks Surge Reduce Positions on Parabolic Moves Swatch and Audemars Piguet Collaboration Sparks Global Watch Frenzy Increased Funding Drives AtHome Hospital Care Expansion Amid Lower Mortality Evidence CapitaLand Unveils 14 Billion Life Sciences Hub Geneo to Transform Science Park Earnings Season in Focus Navigating the Calendar and Analyst Consensus Bank of America Predicts Fed Rate Cuts Unlikely Before Second Half of 2027 Young Job Seeker Highlights Grimsbys Unemployment Challenge as UK Youth Labour Market Struggles AMD Commits 10 Billion to Taiwan AI Chip Manufacturing and Packaging RMBI Q1 2026 Earnings Solid EPS Performance Amid Quiet Quarter Canaan Inc Q1 2026 Earnings Deep EPS Miss Signals Continued Headwinds LPCN Q1 2026 Earnings WiderThanExpected Loss as Company Continues to Advance Pipeline STG Q3 2025 Earnings Reported EPS of 932 Stock Declines 95 Amid Limited Disclosures ACGLN Q1 2026 Earnings Preferred Shares React to Slight EPS Miss Titan Mining Q1 2026 Earnings Strong EPS Surprise Despite Absent Revenue Data Bone Biologics Corp Warrants BBLGW Holding Steady at 1415 After a Flat Session National Vision Holdings EYE Hovers Near Flat as Stock Tests Key Support Levels Ready Capital Corporation RC Slips to 181 Support Test in Focus Greenlight Capital Re Ltd GLRE Slips 251 as Price Pivots Near Key Resistance Zone EPAM Systems Struggles EPAM Stock Slides 29 as Tech Sector Headwinds Persist Renasant Corporation RNST Gains 102 as Stock Approaches Key Resistance Zone SoundHound AI Warrants SOUNW Weaken Amid Broader Tech Volatility Key Support in Focus Avalon Holdings AWX Edges Higher as Stock Tests Key Resistance Zone QuidelOrtho QDEL Drops 43 as Diagnostics Sector Faces Renewed Pressure Lifetime Brands LCUT Faces Modest Pressure Testing Key Support Levels SP 500 Recovers as Tech Surge Offsets Energy Rout Dow Slips MDA Space Q1 2026 Earnings Strong EPS Surprise Drives Stock Rally Intellia Therapeutics NTLA Rebounds GeneEditing Stock Shows Promise Near Support